Unlock AI-driven, actionable R&D insights for your next breakthrough.

L-Methionine As A Sulfur Source: Biosynthetic Pathways, Enzymatic Mechanisms, And Industrial Production Strategies

NOV 17, 202663 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
L-Methionine serves as a critical sulfur source in microbial biosynthesis, enabling direct incorporation of reduced sulfur into amino acid frameworks while bypassing energy-intensive sulfate reduction pathways. This dual functionality—providing both sulfur and methyl groups—has positioned L-Methionine and its derivatives (e.g., methyl mercaptan, dimethyl disulfide) as pivotal substrates in fermentative production systems. Engineered microorganisms leverage enzymes such as O-acetyl-L-homoserine sulfhydrylase (MetY/MetZ) to catalyze sulfhydrylation reactions, achieving yields exceeding 0.14 g/L under optimized conditions 2. Understanding the biochemical mechanisms, metabolic engineering strategies, and process parameters governing L-Methionine's role as a sulfur donor is essential for advancing sustainable amino acid manufacturing and addressing the limitations of traditional sulfate-based fermentation.
Want to know more material grades? Try Patsnap Eureka Material.

Biochemical Foundations Of L-Methionine As A Sulfur Source In Microbial Metabolism

The utilization of L-Methionine as a sulfur source fundamentally alters microbial sulfur assimilation by circumventing the energetically costly reduction of inorganic sulfate (SO₄²⁻) to sulfide (S²⁻). In conventional methionine biosynthesis from sulfate, cells expend 2 ATP, 1 GTP, and 4 NADPH molecules solely for sulfur reduction, in addition to 1 ATP and 2 NADPH required for the core aspartate-to-methionine pathway 13. By contrast, feeding reduced sulfur compounds such as methyl mercaptan (CH₃SH) or dimethyl disulfide (DMDS, CH₃-S-S-CH₃) directly supplies sulfur in a reduced state, eliminating the need for sulfate reductase activity and conserving cellular energy 3,4,6.

Enzymatic Incorporation Of Reduced Sulfur Compounds

Microorganisms such as Corynebacterium glutamicum and Escherichia coli employ O-acetyl-L-homoserine sulfhydrylase (MetY, also designated MetZ) to catalyze the substitution of the acetyl group in O-acetyl-L-homoserine (OAH) with the mercapto group from methyl mercaptan or DMDS, yielding L-Methionine directly 1,7. This reaction bypasses two key enzymes in the canonical pathway: methyltetrahydrofolate reductase (MetF) and methionine synthase (MetE/MetH), which are responsible for methyl group transfer and homocysteine methylation, respectively 3,8. Bolten et al. demonstrated that wildtype C. glutamicum can grow on methyl mercaptan or DMDS as sole sulfur sources, with MetY serving as the primary enzyme for direct methionine synthesis 1,7. Importantly, the MetY/MetZ enzyme exhibits broad substrate specificity, accepting both monomeric (CH₃SH) and dimeric (DMDS) forms of methyl-capped sulfides 4,6.

Metabolic Advantages And Energy Economics

The direct sulfhydrylation route offers several metabolic advantages beyond energy savings. First, it reduces the complexity of the methionine biosynthetic pathway, minimizing the number of genetic modifications required for pathway deregulation 11. Second, it decreases the accumulation of toxic intermediates such as homocysteine, which can inhibit cell growth at elevated concentrations 3. Third, the use of DMDS as a sulfur source is safer and more practical than methyl mercaptan, which is a toxic, explosive, and noxious gas 3,4,6,8. DMDS is a stable liquid at room temperature, readily miscible with aqueous media, and can be enzymatically cleaved to release methyl mercaptan in situ, thereby mitigating handling risks 6,9.

Stoichiometry And Byproduct Formation

A critical consideration in the enzymatic conversion of OAH to L-Methionine is the stoichiometric generation of acetate. For each mole of L-Methionine produced via the MetY-catalyzed reaction, one mole of acetate is released 1,7. At industrial scales, this leads to high acetate concentrations in the culture broth, which can perturb cellular pH homeostasis by diffusing across the membrane in undissociated form and acidifying the cytoplasm 1. To address this challenge, metabolic engineering strategies have been developed to enable acetate reassimilation by the producing strain, thereby improving carbon economy and reducing downstream purification costs 1,14.

Genetic Engineering Strategies For Enhanced L-Methionine Production Using Reduced Sulfur Sources

Deregulation Of Methionine Biosynthesis

Overproduction of L-Methionine in microorganisms requires systematic deregulation of feedback inhibition mechanisms that normally control pathway flux. In C. glutamicum and E. coli, methionine biosynthesis is subject to feedback inhibition by L-Methionine and S-adenosylmethionine (SAM) at multiple enzymatic steps, including homoserine acetyltransferase (MetA) and homoserine dehydrogenase (ThrA) 16. Classical mutagenesis and selection, or site-directed mutagenesis of allosteric sites, can yield deregulated enzyme variants that maintain catalytic activity in the presence of high methionine concentrations 3,4. For example, Zelder et al. demonstrated that strains harboring deregulated O-acetyl-L-homoserine sulfhydrylase or L-homoserine acetyltransferase exhibited enhanced methionine production when cultured with DMDS 1,7,14.

Amplification Of MetY/MetZ And Precursor Supply

To maximize sulfhydrylation efficiency, overexpression of the metY or metZ gene is essential. Introduction of heterologous metZ genes from species such as Chromobacterium violaceum, Hyphomicrobium nitrativorans, or Rhodobacter sphaeroides into C. glutamicum resulted in L-Methionine yields of 0.13–0.14 g/L when thiosulfate (S₂O₃²⁻) was used as the sulfur source, representing a 266% increase over control strains 2,5. Notably, when methyl mercaptan was substituted for thiosulfate, yields remained at 0.02 g/L, suggesting that further optimization of metY/metZ expression levels, codon usage, or enzyme stability is required to fully exploit reduced sulfur sources 2,5.

Concurrent amplification of enzymes responsible for OAH biosynthesis—such as homoserine acetyltransferase (MetA) and homoserine dehydrogenase (ThrA)—is also critical. Strains engineered to overproduce OAH provide a larger substrate pool for MetY/MetZ, thereby increasing methionine flux 1,7. In two-stage bioprocesses, OAH is first accumulated in the culture broth via fermentation, then reacted with methyl mercaptan in a second enzymatic step, achieving higher overall yields 1,7,10.

Deletion Of Competing Pathways

Deletion of genes encoding enzymes that compete for sulfur or methyl donors can further enhance methionine production. For instance, deletion of metF (encoding methyltetrahydrofolate reductase) or dual deletion of metE and metH (encoding methionine synthases) forces cells to rely exclusively on the sulfhydrylation route, thereby channeling all reduced sulfur toward methionine synthesis 3,4,8. A ΔmetF ΔmetB strain of C. glutamicum was shown to utilize DMDS as both a sulfur and methyl source, with methionine production improved by the addition of DMDS to prototrophic strains overproducing OAH 3,4,8.

Introduction Of Thiocarboxylate-Dependent Pathways

Recent advances have explored the use of thiocarboxylated proteins as sulfur donors in methionine biosynthesis. In this system, sulfur is mobilized from cysteine desulfurases (e.g., IscS) and transferred to carrier proteins (e.g., ThiS), which then donate sulfur to MetY/MetZ or related enzymes 16. Overexpression of genes encoding thiocarboxylate biosynthesis machinery, combined with deregulated homoserine O-acetyltransferase and O-acetylhomoserine sulfhydrylase, has been shown to improve methionine yields in fermentation 16. This approach reduces reliance on exogenous reduced sulfur compounds, potentially lowering production costs and simplifying process control.

Process Parameters And Fermentation Strategies For L-Methionine Production

Sulfur Source Selection And Feeding Strategies

The choice of sulfur source profoundly impacts both yield and process safety. Dimethyl disulfide (DMDS) is preferred over methyl mercaptan due to its lower toxicity, reduced volatility, and ease of handling 3,4,6,8. DMDS can be added directly to the culture medium, where it is enzymatically or chemically reduced to methyl mercaptan in situ 6,9. Typical DMDS concentrations range from 0.5 to 5 g/L, with higher concentrations potentially inhibiting cell growth due to osmotic stress or toxicity 4,6. Continuous or fed-batch feeding strategies are often employed to maintain DMDS levels within an optimal window, thereby maximizing methionine production while minimizing substrate inhibition 1,7.

Thiosulfate (S₂O₃²⁻) represents an intermediate option, providing one reduced sulfur atom per molecule and requiring less energy for assimilation than sulfate 3,11. However, thiosulfate-based processes still necessitate partial sulfur reduction and do not supply a methyl group, limiting their efficiency relative to DMDS or methyl mercaptan 3,11.

Culture Medium Composition And Nutrient Balance

Fermentation media for methionine production typically contain glucose (20–40 g/L) as the carbon source, ammonium salts (5–10 g/L) as the nitrogen source, and trace elements including biotin (100 µg/L), thiamine HCl (1000 µg/L), calcium pantothenate (2000 µg/L), nicotinamide (3000 µg/L), and cobalamin (1 µg/L) 2,5. Calcium carbonate (30 g/L) is often added to buffer pH fluctuations caused by acetate accumulation 2,5. Optimization of the C:N:S ratio is critical; excess carbon can lead to overflow metabolism and acetate accumulation, while sulfur limitation reduces methionine yields 1,7.

Temperature, pH, And Aeration Control

Optimal fermentation temperatures for C. glutamicum and E. coli range from 30 to 37°C, with pH maintained between 6.5 and 7.5 using automated acid/base addition 1,7. Dissolved oxygen (DO) levels should be kept above 20% saturation to support aerobic metabolism, though excessive aeration can volatilize methyl mercaptan, reducing its availability for methionine synthesis 1,7. Agitation rates of 200–400 rpm and aeration rates of 0.5–1.5 vvm are typical for laboratory-scale fermentations 2,5.

Two-Stage Bioprocesses

Two-stage processes separate OAH production (Stage 1) from methionine synthesis (Stage 2), enabling independent optimization of each step 1,7,10. In Stage 1, a recombinant strain overproducing OAH is cultured under conditions favoring precursor accumulation (e.g., high glucose, low sulfur). The cell-free supernatant or whole-cell lysate is then transferred to Stage 2, where methyl mercaptan or DMDS is added along with purified MetY/MetZ enzyme or a second microbial strain expressing high levels of sulfhydrylase activity 1,7,10. This approach minimizes toxicity to the OAH-producing strain and allows for higher methionine yields, though it increases process complexity and capital costs 1,7,10.

Applications Of L-Methionine As A Sulfur Source In Industrial Biotechnology

Animal Feed And Nutrition

L-Methionine is an essential amino acid for poultry, swine, and aquaculture, where it serves as a limiting nutrient in plant-based diets 13,16. Fermentative production of L-Methionine using reduced sulfur sources offers a sustainable alternative to chemical synthesis, which generates racemic D,L-methionine and requires hazardous reagents such as acrolein and hydrogen cyanide 3,13. Pure L-Methionine exhibits superior bioavailability and growth-promoting effects compared to the racemic mixture, justifying the higher production costs associated with fermentation 13,16. Current industrial fermentation processes for lysine, threonine, and tryptophan demonstrate the technical and economic feasibility of amino acid production from renewable feedstocks, providing a roadmap for methionine commercialization 13,16.

Pharmaceutical And Nutraceutical Applications

L-Methionine and its derivative S-adenosyl-L-methionine (SAM) are used in pharmaceutical formulations for liver support, detoxification, and treatment of depression and osteoarthritis 10. SAM is synthesized from L-Methionine via ATP-dependent methylation and serves as a universal methyl donor in cellular metabolism 10. Fermentative production of L-Methionine ensures enantiomeric purity and eliminates contamination risks associated with chemical synthesis, meeting stringent regulatory requirements for pharmaceutical-grade amino acids 10,13. Typical pharmaceutical applications require L-Methionine purities exceeding 99%, necessitating advanced downstream processing including crystallization, ion-exchange chromatography, and recrystallization 10,13.

Biosynthesis Of Sulfur-Containing Fine Chemicals

L-Methionine serves as a precursor for the biosynthesis of other sulfur-containing compounds, including cysteine, taurine, and glutathione 10,12. Metabolic engineering strategies that enhance methionine production can be extended to these downstream products by introducing or amplifying relevant biosynthetic enzymes. For example, overexpression of cystathionine γ-synthase and cystathionine β-lyase in methionine-overproducing strains enables efficient conversion of methionine to cysteine 12. Similarly, taurine biosynthesis can be achieved by introducing cysteine dioxygenase and cysteine sulfinic acid decarboxylase into methionine-producing platforms 12. These integrated bioprocesses leverage the same reduced sulfur sources and metabolic engineering principles, offering economies of scale and process simplification 12.

Environmental And Sustainability Considerations

Fermentative production of L-Methionine using reduced sulfur sources aligns with principles of green chemistry and sustainable manufacturing. By utilizing renewable carbon sources (e.g., glucose, sucrose) and eliminating toxic reagents (e.g., acrolein, methyl mercaptan gas), fermentation processes reduce environmental impact and improve worker safety 3,13. Additionally, the use of DMDS as a sulfur source minimizes greenhouse gas emissions associated with sulfate reduction, as the latter requires significant energy input and generates hydrogen sulfide (H₂S) as a byproduct 3,13. Life cycle assessments indicate that fermentative methionine production can achieve carbon footprints 30–50% lower than chemical synthesis, provided that downstream processing is optimized to minimize energy consumption 13.

Challenges And Future Directions In L-Methionine Production Using Reduced Sulfur Sources

Enzyme Engineering For Enhanced Sulfhydrylase Activity

Despite significant progress, current MetY/MetZ variants exhibit suboptimal activity with methyl mercaptan and DMDS, limiting methionine yields 2,5. Directed evolution and rational design approaches can be employed to improve enzyme kinetics, substrate affinity, and resistance to feedback inhibition. For example, saturation mutagenesis of active-site residues or domain-swapping experiments between MetY homologs from different species may yield variants with 2- to 5-fold higher specific activity 2,5. High-throughput screening platforms based on

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
Evonik Degussa GmbHIndustrial fermentation production of L-methionine for animal feed and pharmaceutical applications, particularly in systems requiring reduced energy consumption and elimination of toxic methyl mercaptan handling.Methionine Fermentation PlatformUtilizes dimethyl disulfide (DMDS) as sulfur source with MetY enzyme, enabling direct L-methionine synthesis while bypassing energy-intensive sulfate reduction (saving 2 ATP, 1 GTP, 4 NADPH per molecule). Acetate reassimilation by engineered strains improves carbon economy.
CJ CheilJedang CorporationMicrobial fermentation systems for L-methionine production in animal nutrition and feed additives, enabling sustainable amino acid manufacturing from renewable feedstocks.MetZ-Enhanced L-Methionine Production SystemIntroduction of heterologous metZ genes (from Chromobacterium violaceum, Hyphomicrobium nitrativorans, Rhodobacter sphaeroides) achieved 266% increase in L-methionine yield (0.13-0.14 g/L) using thiosulfate as sulfur source, with reduced feedback inhibition compared to native enzymes.
BASF SEFermentative L-methionine production for pharmaceutical-grade applications and animal feed, particularly in facilities requiring improved worker safety and reduced hazardous material handling.DMDS-Based Methionine Biosynthesis TechnologyEngineered ΔmetF or ΔmetE/ΔmetH strains utilize DMDS as both sulfur and methyl donor, bypassing MetF and MetH/MetE enzymes. DMDS offers safer handling than methyl mercaptan (non-explosive liquid vs. toxic gas) while maintaining sulfhydrylation efficiency.
Arkema FranceIndustrial-scale L-methionine production requiring high purity (>99%) for pharmaceutical and nutraceutical applications, including S-adenosyl-L-methionine (SAM) synthesis for liver support and neurological treatments.Two-Stage Enzymatic Methionine SynthesisSeparates O-acetyl-L-homoserine (OAH) production from methionine synthesis via MetY/MetZ-catalyzed sulfhydrylation with DMDS or methyl mercaptan, enabling independent optimization of each stage and minimizing toxicity to precursor-producing strains.
Evonik Operations GmbHSustainable fermentative production of L-methionine and sulfur-containing fine chemicals (cysteine, taurine, glutathione) for animal feed, pharmaceuticals, and biosynthesis applications with reduced environmental impact.Thiocarboxylate-Dependent Methionine Production SystemEmploys thiocarboxylated proteins (via IscS/ThiS system) as sulfur donors combined with deregulated homoserine O-acetyltransferase and O-acetylhomoserine sulfhydrylase, reducing reliance on exogenous reduced sulfur compounds and lowering production costs.
Reference
  • Method for producing l-methionine
    PatentActiveIN201817023028A
    View detail
  • L-methionine producing microorganism to which protein encoded by foreign metz gene is introduced and method for producing l-methionine using same
    PatentPendingSG11202204278PA
    View detail
  • METHODS FOR PRODUCING METHIONINE, FOR IMPROVING THE USE OF DMDS FOR METHIONINE PRODUCTION, AND FOR IDENTIFYING A MUTANT ALLELE, COMPOSITION, METHIONINE-CONTAINING PRODUCT, MICROORGANISM, ISOLATED GENE, MUTANT O-ACETYL-HOMOSERINE SULFHYDRASE OR O-SUCCINYL-HOMOSERINE SULFHYDRASE ENZYMES, AND ORGANISM
    PatentInactiveBRPI0612900A2
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png